Jianyi "Jay" Zhang, University of Alabama at Birmingham (IMAGE)

University of Alabama at Birmingham

Jianyi "Jay" Zhang, University of Alabama at Birmingham

Caption

"These results suggest that the cyclin D2-cardiomyocyte transplantation may be a potential therapeutic strategy for the repair of infarcted hearts," said study leader Jianyi "Jay" Zhang, M.D., Ph.D., the chair of Biomedical Engineering, a joint department of the UAB School of Medicine and the UAB School of Engineering.

Credit

UAB

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.